Catalog #DRA125
| Cat # | Size | Price | Quantity | |
|---|---|---|---|---|
| DRA125 | 50ug | $190.00 | ||
| DRA125 | 500ug | $1,500.00 | ||
| DRA125 | 1mg | $2,300.00 |
Recombinant SARS-CoV-2 S Protein RBD (501Y.V2) is produced by our Mammalian expression system and the target gene encoding Arg319-Phe541(K417N,E484K,N501Y) is expressed with a 6His tag at the C-terminus. The mutations were identified in the SARS-CoV-2 variant (known as 20C/501Y.V2 or B.1.351 lineage) which emerged in South Africa.
| Application fields | In Vitro Diagnostics |
|---|---|
| Protein Tag | C-6His |
| Species | SARS-CoV-2 |
| Alias | 2019-nCov RBD Protein; 2019-nCoV Spike RBD Protein |
| Accession No | QHD43416.1 |
| Formulation | Supplied as a 0.2 μm filtered solution of PBS, pH 7.4 |
| Purity | > 95% by SDS-PAGE under reducing conditions |
| Expression System | Human Cells |